-
公开(公告)号:EA004955B1
公开(公告)日:2004-10-28
申请号:EA200200574
申请日:2002-06-17
Applicant: SERVIER LAB
Inventor: WIERZBICKI MICHEL , FOURQUEZ JEAN-MARIE , LEVENS NIGEL , HUSSON-ROBERT BERNADETTE , NOSJEAN OLIVER , BOULANGER MICHELLE
IPC: C07D295/18 , A61K31/16 , A61K31/397 , A61K31/40 , A61K31/403 , A61K31/426 , A61K31/4453 , A61K31/5375 , A61P3/00 , A61P3/04 , A61P3/10 , C07C237/14 , C07D205/04 , C07D207/18 , C07D207/20 , C07D209/02 , C07D209/52 , C07D277/04 , C07D277/22 , C07D295/185 , A61K31/4025
Abstract: Соединениеформулы (I)вкоторойпредставляетсобойнеобязательнозамещенноенасыщенноеуглеводородноекольцо, имеющееот 4 до 8 атомовуглеродав кольце,Rи R, которыемогутбытьодинаковымиилиразличными, каждыйпредставляетсобойатомводородаилиацильнуюгруппу,Rи R, которыемогутбытьодинаковымиилиразличными, каждыйпредставляетсобойатомводородаилиалкильнуюгруппу,Rи R, которыемогутбытьодинаковымиилиразличными, каждыйпредставляетсобойатомводородаилиалкильнуюгруппу,или Rи Rсовместнос атомомазота, ихнесущим, образуютнеобязательнозамещенныйазотсодержащийгетероцикл,егостереоизомеры, атакжеегоаддитивныесолис фармацевтическиприемлемойкислотой.Лекарственныепрепараты.
-
公开(公告)号:AR034516A1
公开(公告)日:2004-02-25
申请号:ARP020102275
申请日:2002-06-18
Applicant: SERVIER LAB
Inventor: WIERZBICKI MICHEL , FOURQUEZ JEAN-MARIE , LEVENS NIGEL , HUSSON-ROBERT BERNADETTE , NOSJEAN OLIVIER , BOULANGER MICHELLE
IPC: C07D295/18 , A61K31/16 , A61K31/397 , A61K31/40 , A61K31/403 , A61K31/426 , A61K31/4453 , A61K31/5375 , A61P3/00 , A61P3/04 , A61P3/10 , C07C237/14 , C07D205/04 , C07D207/18 , C07D207/20 , C07D209/02 , C07D209/52 , C07D277/04 , C07D277/22 , C07D295/185 , A61K31/675 , A61K31/155 , A61K31/401 , A61K31/44
Abstract: Compuestos de la fórmula (1) donde A representa un anillo de carbono saturado opcionalmente sustitutido que tiene entre 4 y 8 miembros de anillo, R1 y R4 que pueden ser idénticos o diferentes, representan, cada uno un átomo de hidrógeno o un grupo acilo, R2 y R3 que pueden ser idénticos o diferentes, representan, cada uno, un átomo de hidrógeno o un grupo alquilo, R5 y R6, que pueden ser idénticos o diferentes, representan, cada uno un átomo de hidrógeno o un grupo alquilo, o R5 y R6 juntos, con el átomo de nitrógeno que los lleva, forman un heterociclo con contenido de nitrógeno opcionalmente sustituido, estereoisómeros de los mismos, y también, sales de adición de los mismos con un ácido farmacéuticamente aceptable. Medicamentos antidiabéticos.
-
公开(公告)号:FR2826003B1
公开(公告)日:2003-08-15
申请号:FR0107934
申请日:2001-06-18
Applicant: SERVIER LAB
Inventor: WIERZBICKI MICHEL , FOURQUEZ JEAN MARIE , LEVENS NIGEL , HUSSON ROBERT BERNADETTE , NOSJEAN OLIVIER , BOULANGER MICHELLE
IPC: C07D295/18 , A61K31/16 , A61K31/397 , A61K31/40 , A61K31/403 , A61K31/426 , A61K31/4453 , A61K31/5375 , A61P3/00 , A61P3/04 , A61P3/10 , C07C237/14 , C07D205/04 , C07D207/18 , C07D207/20 , C07D209/02 , C07D209/52 , C07D277/04 , C07D277/22 , C07D295/185 , C07D207/12
Abstract: A compound of formula (I):wherein:represents an optionally substituted saturated carbon ring having from 4 to 8 ring members,R1 and R4, which may be identical or different, each represents hydrogen or acyl,R2 and R3, which may be identical or different, each represents hydrogen or alkyl,R5 and R6, which may be identical or different, each represents hydrogen or alkyl, or R5 and R6 together, with the nitrogen atom carrying them, form an optionally substituted nitrogen-containing heterocycle,stereoisomers thereof, and also addition salts thereof with a pharmaceutically acceptable acid.Medicinal products containing the same which are useful for treatment of glucose intolerance or of disorders associated with hyperglycaemia.
-
公开(公告)号:HK1050186A1
公开(公告)日:2003-06-13
申请号:HK03102394
申请日:2003-04-03
Applicant: SERVIER LAB
Inventor: WIERZBICKI MICHEL , FOURQUEZ JEAN-MARIE , LEVENS NIGEL , HUSSON-ROBERT BERNADETTE , NOSJEAN OLIVIER , BOULANGER MICHELLE
IPC: C07D295/18 , A61K31/16 , A61K31/397 , A61K31/40 , A61K31/403 , A61K31/426 , A61K31/4453 , A61K31/5375 , A61P3/00 , A61P3/04 , A61P3/10 , C07C237/14 , C07D205/04 , C07D207/18 , C07D207/20 , C07D209/02 , C07D209/52 , C07D277/04 , C07D277/22 , C07D295/185 , C07C , C07D , A61K , A61P
Abstract: A compound of formula (I):wherein:represents an optionally substituted saturated carbon ring having from 4 to 8 ring members,R1 and R4, which may be identical or different, each represents hydrogen or acyl,R2 and R3, which may be identical or different, each represents hydrogen or alkyl,R5 and R6, which may be identical or different, each represents hydrogen or alkyl, or R5 and R6 together, with the nitrogen atom carrying them, form an optionally substituted nitrogen-containing heterocycle,stereoisomers thereof, and also addition salts thereof with a pharmaceutically acceptable acid.Medicinal products containing the same which are useful for treatment of glucose intolerance or of disorders associated with hyperglycaemia.
-
公开(公告)号:HU0201646A2
公开(公告)日:2003-02-28
申请号:HU0201646
申请日:2002-05-14
Applicant: SERVIER LAB
Inventor: BENOIST ALAIN , BOULANGER MICHELLE , HUSSON-ROBERT BERNADETTE , LEVENS NIGEL , DE NANTEUIL GUILLAUME , NOSJEAN OLIVIER , PORTEVIN BERNARD
IPC: A61K31/40 , C07D295/10 , A61K31/426 , A61P3/04 , A61P3/08 , A61P3/10 , C07D207/16 , C07D277/04 , C07D277/06 , C07D295/185 , C07K5/02
Abstract: Alpha amino acid derivatives (I), their optical isomers and addition salts, are new. Alpha amino acid derivatives of formula (I), their optical isomers and addition salts, are new: A = five-membered heterocycle, optionally substituted by a cyano group; Ak = 1-6C alkylene; X = single bond or phenylene; R1, R2, R4 = H or 1-6C alkyl; Y = NR4 or CH-NO2; R3 = NO2 or CN; and provided that: (i) when Y is CH-NO2, then R3 may further be 1-6C alkyl; and (ii) when A is unsubstituted, then Ak is propylene, X is a bond, Y is NH and R3 is NO2, are excluded.
-
公开(公告)号:ZA200204865B
公开(公告)日:2003-02-20
申请号:ZA200204865
申请日:2002-06-18
Applicant: SERVIER LAB
Inventor: WIERZBICKI MICHEL , FOURQUEZ JEAN-MARIE , LEVENS NIGEL , HUSSON-ROBERT BERNADETTE , NOSJEAN OLIVIER , BOULANGER MICHELLE
IPC: A61K31/16 , A61K31/397 , A61K31/40 , A61K31/403 , C07D295/18 , A61K31/426 , A61K31/4453 , A61K31/5375 , A61P3/00 , A61P3/04 , A61P3/10 , C07C237/14 , C07D205/04 , C07D207/18 , C07D207/20 , C07D209/02 , C07D209/52 , C07D277/04 , C07D277/22 , C07D295/185 , C07C , C07D , A61K , A61P
Abstract: A compound of formula (I):wherein:represents an optionally substituted saturated carbon ring having from 4 to 8 ring members,R1 and R4, which may be identical or different, each represents hydrogen or acyl,R2 and R3, which may be identical or different, each represents hydrogen or alkyl,R5 and R6, which may be identical or different, each represents hydrogen or alkyl, or R5 and R6 together, with the nitrogen atom carrying them, form an optionally substituted nitrogen-containing heterocycle,stereoisomers thereof, and also addition salts thereof with a pharmaceutically acceptable acid.Medicinal products containing the same which are useful for treatment of glucose intolerance or of disorders associated with hyperglycaemia.
-
公开(公告)号:NO20022891D0
公开(公告)日:2002-06-17
申请号:NO20022891
申请日:2002-06-17
Applicant: SERVIER LAB
Inventor: WIERZBICKI MICHEL , FOURQUEZ JEAN-MARIE , LEVENS NIGEL , HUSSON-ROBERT BERNADETTE , NOSJEAN OLIVIER , BOULANGER MICHELLE
IPC: A61K31/16 , C07D295/18 , A61K31/397 , A61K31/40 , A61K31/403 , A61K31/426 , A61K31/4453 , A61K31/5375 , A61P3/00 , A61P3/04 , A61P3/10 , C07C237/14 , C07D205/04 , C07D207/18 , C07D207/20 , C07D209/02 , C07D209/52 , C07D277/04 , C07D277/22 , C07D295/185 , C07D
Abstract: A compound of formula (I):wherein:represents an optionally substituted saturated carbon ring having from 4 to 8 ring members,R1 and R4, which may be identical or different, each represents hydrogen or acyl,R2 and R3, which may be identical or different, each represents hydrogen or alkyl,R5 and R6, which may be identical or different, each represents hydrogen or alkyl, or R5 and R6 together, with the nitrogen atom carrying them, form an optionally substituted nitrogen-containing heterocycle,stereoisomers thereof, and also addition salts thereof with a pharmaceutically acceptable acid.Medicinal products containing the same which are useful for treatment of glucose intolerance or of disorders associated with hyperglycaemia.
-
公开(公告)号:CA2389858C
公开(公告)日:2007-08-28
申请号:CA2389858
申请日:2002-06-18
Applicant: SERVIER LAB
Inventor: BOULANGER MICHELLE , NOSJEAN OLIVIER , WIERZBICKI MICHEL , HUSSON-ROBERT BERNADETTE , LEVENS NIGEL , FOURQUEZ JEAN-MARIE
IPC: C07D295/04 , C07D295/18 , A61K31/16 , A61K31/397 , A61K31/40 , A61K31/401 , A61K31/403 , A61K31/426 , A61K31/445 , A61K31/4453 , A61K31/5375 , A61P3/00 , A61P3/04 , A61P3/10 , C07C231/00 , C07C233/08 , C07C237/14 , C07D205/04 , C07D207/04 , C07D207/18 , C07D207/20 , C07D209/02 , C07D209/52 , C07D277/02 , C07D277/04 , C07D277/22 , C07D295/02 , C07D295/185
Abstract: L'invention concerne de nouveaux composés répondant à la formule (I) (voir formule I) dans laquelle ~ représente un cycle carboné saturé de 4 à 8 chaînons éventuellement substitué; R1 et R4, identiques ou différents, représentent chacun un atome d'hydrogène ou un groupement acyle; R2 et R3, identiques ou différents, représentent chacun un atome d'hydrogène ou un groupement alkyle; R5 et R6, identiques ou différents, représentent chacun un atome d'hydrogène ou un groupement alkyle, ou bien R5 et R6 formen t ensemble, avec l'atome d'azote qui les porte, un hétérocycle azoté éventuellement substitué. L'invention vise également les stéréoisomères des compôsés de formule (I) ainsi que leurs sels d'addition à un acide pharmaceutiquement acceptable. Les composés selon l'invention sont utiles à titre de médicaments pour le traitement de l'intolérance au glucose ou des maladies associées à une hyperglycémie.
-
公开(公告)号:ES2229063T3
公开(公告)日:2005-04-16
申请号:ES02291501
申请日:2002-06-17
Applicant: SERVIER LAB
Inventor: WIERZBICKI MICHEL , FOURQUEZ JEAN-MARIE , LEVENS NIGEL , HUSSON-ROBERT BERNADETTE , NOSJEAN OLIVIER , BOULANGER MICHELLE
IPC: C07D295/18 , A61K31/16 , A61K31/397 , A61K31/40 , A61K31/403 , A61K31/426 , A61K31/4453 , A61K31/5375 , A61P3/00 , A61P3/04 , A61P3/10 , C07C237/14 , C07D205/04 , C07D207/18 , C07D207/20 , C07D209/02 , C07D209/52 , C07D277/04 , C07D277/22 , C07D295/185
Abstract: Compuesto de **fórmula** en la cual: - representa un ciclo carbonado saturado de 4 a 8 eslabones, eventualmente sustituido por uno o varios grupos alquilo de 1 a 6 carbonos, lineales o ramificados, - R1 y R4, idénticos o diferentes, representan cada uno un átomo de hidrógeno o un grupo acilo de 1 a 6 carbonos lineal o ramificado, - R2 y R3, idénticos o diferentes, representan cada uno un átomo de hidrógeno o un grupo alquilo de 1 a 6 carbonos lineal o ramificado, - R5 y R6, idénticos o diferentes, representan cada uno un átomo de hidrógeno o un grupo alquilo de 1 a 6 carbonos lineal o ramificado, o bien R5 y R6 forman juntos, con el átomo de nitrógeno que los porta, un heterociclo nitrogenado eventualmente sustituido por uno o varios grupos, idénticos o diferentes, elegidos de entre un grupo ciano, CO2R7 (en el cual R7 representa un átomo de hidrógeno o un grupo alquilo de 1 a 6 carbonos lineal o ramificado), COR7 (en el cual R7 es tal y como está definido anteriormente), nitro, CONR8aR8b (en el cual R8a y R8b, idénticos o diferentes, representan cada uno un átomo de hidrógeno o un grupo alquilo de 1 a 6 carbonos lineal o ramificado, o bien R8a y R8b forman juntos un heterociclo nitrogenado), S(O)nR9 (en el cual n es 1, 2 o 3, y R9 representa un átomo de hidrógeno, un grupo alquilo de 1 a 6 carbonos lineal o ramificado o un arilo), o PO3R10aR10b (en el cual R10a y R10b, idénticos o diferentes, representan cada uno un átomo de hidrógeno o un grupo alquilo de 1 a 6 carbonos lineal o ramificado), sus estereoisómeros, así como sus sales de adición a un ácido farmacéuticamente aceptable.
-
30.
公开(公告)号:AU780480B2
公开(公告)日:2005-03-24
申请号:AU4065402
申请日:2002-05-15
Applicant: SERVIER LAB
Inventor: NANTEUIL GUILLAUME DE , BENOIST ALAIN , PORTEVIN BERNARD , LEVENS NIGEL , NOSJEAN OLIVIER , HUSSON-ROBERT BERNADETTE , BOULANGER MICHELLE
IPC: C07D295/10 , A61K31/40 , A61K31/426 , A61P3/04 , A61P3/08 , A61P3/10 , C07D207/16 , C07D277/04 , C07D277/06 , C07D295/185 , C07K5/02 , A61K31/401 , C07D277/22 , C07D277/30 , C07D295/192
Abstract: Alpha amino acid derivatives (I), their optical isomers and addition salts, are new. Alpha amino acid derivatives of formula (I), their optical isomers and addition salts, are new: A = five-membered heterocycle, optionally substituted by a cyano group; Ak = 1-6C alkylene; X = single bond or phenylene; R1, R2, R4 = H or 1-6C alkyl; Y = NR4 or CH-NO2; R3 = NO2 or CN; and provided that: (i) when Y is CH-NO2, then R3 may further be 1-6C alkyl; and (ii) when A is unsubstituted, then Ak is propylene, X is a bond, Y is NH and R3 is NO2, are excluded.
-
-
-
-
-
-
-
-
-